Company Description

Globally, one in ten women will suffer from endometriosis, a painful and debilitating gynecological condition. Afynia has created the first and only patented blood test for diagnosing endometriosis early. It returns a result in days, not years, and will be offered through clinics and home collection kits beginning in 2024. Afynia is building a digital women’s health platform that will provide diagnostics, virtual care, and prescription deliveries for endometriosis and other conditions. With Afynia, women have the opportunity to become full-fledged partners in their own healthcare.